Verition Fund Management LLC is a multi-strategy, multi-manager hedge fund that focuses on a diverse range of global investment strategies. These include Credit, Fixed Income & Macro, Convertible & Volatility Arbitrage, Event-Driven, Equity Long/Short & Capital Markets, and Quantitative Strategies. The firm typically participates in various investment rounds, including Series A, B, C, and D, with investments in companies raising significant capital.
Notable portfolio companies include Amylyx Pharmaceuticals, Biosplice Therapeutics, Evommune, Georgiamune, Korro Bio, and Vedanta Biosciences. Verition's team comprises experienced portfolio managers with backgrounds in proprietary trading desks and client account management. The firm's investment philosophy emphasizes diversified strategies aimed at driving absolute returns. Verition also offers unique value-add services through its multifaceted infrastructure, supporting portfolio companies with strategic insights and operational expertise.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
